Verification evidence is still being completed.
PDF / print export
CeGaT GmbH
Tuebingen, Germany
- Verified lead
- Saskia Biskup
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Managing Director and Co-Founder
- 2026 technical specialization
- Clinical NGS Diagnostics, Whole-Exome and Whole-Genome Sequencing, and Genomic Research Services
- Review cycle
- 24 April 2026
- Full address
- Paul-Ehrlich-Strasse 23, 72076 Tuebingen, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- CeGaT team page listing Saskia Biskup and Dirk Biskup as joint Managing Directors and co-founders.
- Editorial note
- Tuebingen clinical genomics operator with named co-founder managing directors, ISO 15189 and ISO 17025 accreditations, and CAP and CLIA recognition for cross-border clinical reporting.
Clinical NGS Diagnostics, Whole-Exome and Whole-Genome Sequencing, and Genomic Research Services
DIN EN ISO 15189, DIN EN ISO 17025, CAP and CLIA recognition
Tuebingen clinical genomics operator with named co-founder managing directors, ISO 15189 and ISO 17025 accreditations, and CAP and CLIA recognition for cross-border clinical reporting.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Tuebingen clinical genomics operator with named co-founder managing directors, ISO 15189 and ISO 17025 accreditations, and CAP and CLIA recognition for cross-border clinical reporting.
- Lead
- Saskia Biskup (verified ↗)
- Address
- Paul-Ehrlich-Strasse 23, 72076 Tuebingen, Germany (source ↗)
- Compliance
- DIN EN ISO 15189 · DIN EN ISO 17025
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Clinical and research genomic service delivery
- Capabilities
- Clinical Diagnostic NGS Panels and Exomes · Whole-Genome and Transcriptome Sequencing · In-House Medical Bioinformatics
- Founded
- 2009
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Saskia Biskup
Managing Director and Co-Founder
Full addressPaul-Ehrlich-Strasse 23, 72076 Tuebingen, Germany
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Clinical and research genomic service delivery
Tuebingen, Germany. Clinical NGS Diagnostics, Whole-Exome and Whole-Genome Sequencing, and Genomic Research Services. Review completed on 24 Apr 2026.
DAkkS accreditation and CAP/CLIA clinical-laboratory oversight
DIN EN ISO 15189, DIN EN ISO 17025, CAP and CLIA recognition
Clinical NGS Diagnostics, Whole-Exome and Whole-Genome Sequencing, and Genomic Research Services
Tuebingen clinical genomics operator with named co-founder managing directors, ISO 15189 and ISO 17025 accreditations, and CAP and CLIA recognition for cross-border clinical reporting.
Editorial note
CeGaT anchors German clinical genomics with documented ISO 15189 and ISO 17025 accreditations, CAP and CLIA recognition for cross-border clinical reporting, and a named co-founder managing team with deep in-house bioinformatics capability.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Clinical Diagnostic NGS Panels and Exomes
Whole-Genome and Transcriptome Sequencing
In-House Medical Bioinformatics
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
NGS sequencing platforms
Single-cell and long-read systems
In-house medical bioinformatics pipelines
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is CeGaT GmbH located?
- CeGaT GmbH operates from Paul-Ehrlich-Strasse 23, 72076 Tuebingen, Germany, Tuebingen, Germany.
- Who runs CeGaT GmbH?
- CeGaT GmbH is led by Saskia Biskup, Managing Director and Co-Founder. Verified 24 Apr 2026.
- What certifications does CeGaT GmbH hold?
- CeGaT GmbH is documented under DIN EN ISO 15189, DIN EN ISO 17025.
- What does CeGaT GmbH do?
- Tuebingen clinical genomics operator with named co-founder managing directors, ISO 15189 and ISO 17025 accreditations, and CAP and CLIA recognition for cross-border clinical reporting. Core capabilities: Clinical Diagnostic NGS Panels and Exomes, Whole-Genome and Transcriptome Sequencing, In-House Medical Bioinformatics.
Editorial context
Related technical briefs
Briefs that name Tuebingen as a covered market or city.